Abstract Number: 2597 • 2014 ACR/ARHP Annual Meeting
Impact of Repeating Imaging of the Sacro-Iliac Joints over One Year on the Classification According the ASAS Axial Spa Criteria of Patients
Background/Purpose: It is known that in axial spondyloarthritis (axSpA) inflammatory lesions on MRI of the SI joints (MRI-SI) can change over time. The usefulness of…Abstract Number: 2596 • 2014 ACR/ARHP Annual Meeting
Similarities and Differences Between Axial and Peripheral Predominant Forms in patients with Early Spondyloarthritis (SpA): Results from the Esperanza Cohort
Background/Purpose: Based on the predominant manifestation of the disease, the ASAS classification criteria for spondyloarthritis (SpA) distinguish two clinical forms: •Axial SpA, including non-radiographic SpA…Abstract Number: 2595 • 2014 ACR/ARHP Annual Meeting
Using Iphone Compass Application for the Assessment of Cervical Rotation in Patients with Ankylosing Spondylitis
Background/Purpose Cervical rotation reflects restriction of mobility in axial disease in ankylosing spondylitis (AS) and it can be assessed in several approaches based on the…Abstract Number: 2594 • 2014 ACR/ARHP Annual Meeting
Differences in Localization and Activity of the Entheseal Involvement Between Non-Radiographic and Radiographic Axial Spondyloarthritis By the Ultrasound Assessment
Background/Purpose Inflammatory involvement of peripheral enthesis belongs to an important sign of spondyloarthritis (SpA). It may occur in patients with long-term as well as newly…Abstract Number: 2613 • 2014 ACR/ARHP Annual Meeting
Positive Spine MRI for Inflammation Predicts Radiographic Progression in Patients with Ankylosing Spondylitis
Background/Purpose: Inflammation at vertebral corners on MRI has been shown to predict development of syndesmophytes in patients with AS. However, it is unclear at a…Abstract Number: 2612 • 2014 ACR/ARHP Annual Meeting
Different Performance of the Major Disease Activity Measures ASDAS and Basdai in Patients with Axial Spondyloarthritis Treated with Non-Steroidal Anti-Inflammatory Agents – Results from a Prospective Study
Background/Purpose: The ASAS/EULAR recommendations for the management of patients (pts) with axial spondyloarthritis (axSpA) have established non-steroidal anti-inflammatory agents (NSAIDs) as first choice of medical…Abstract Number: 2611 • 2014 ACR/ARHP Annual Meeting
Short Term Efficacy of Tumor Necrosis Factor Inhibitors in Patients with non–radiographic Axial Spondylarthritis and ankylosing Spondylitis; Results from Turkbio Registry
Background/Purpose Axial spondylarthritis (AxSpA) has been proposed as an umbrella term for ankylosing spondylitis (AS) and non-radiographic (nr) AxSpA). This new concept makes diagnosis of…Abstract Number: 2610 • 2014 ACR/ARHP Annual Meeting
The Role of IL-20 in the Pathogenesis of Ankylosing Spondylitis with Peripheral Joint Involvement
Background/Purpose The interleukin-20 (IL-20) is a pro-inflammatory cytokine of the IL-10 family and sequence amino acid is very similar. It has been reported to be…Abstract Number: 2609 • 2014 ACR/ARHP Annual Meeting
Treating Axial-Spa to Target: Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Anti-TNFα Agents
Background/Purpose . Treating disease to target is emerging as the recommended strategy also in the management of axial-SpA (axSpA) (1). Reaching remission, defined as inactive…Abstract Number: 2608 • 2014 ACR/ARHP Annual Meeting
Do You Assess Gastro-Intestinal Auto-Antibodies and Symptoms in Patients with Spondyloarthritis?
Background/Purpose Spondyloarthritis (SpA) are a group of chronic inflammatory rheumatic diseases. Extra-articular manifestations affect approximately 30% of patients with SpA, and gastrointestinal manifestations (GI) represents…Abstract Number: 2607 • 2014 ACR/ARHP Annual Meeting
Fatigue in Ankylosing Spondylitis: A Multivariable Analysis Implicates Inflammation As the Key Determinant of Disability
Background/Purpose: Fatigue is one of the cardinal features of ankylosing spondylitis (AS). The clinical and laboratory correlates of fatigue in AS however are not well…Abstract Number: 2606 • 2014 ACR/ARHP Annual Meeting
How to Classify Spondyloarthritis after a Two Year Follow up? Results from the French Recent onset spondyloarthritis Cohort
Background/Purpose: In early arthritis, after a two years follow up, rheumatologist diagnosis of rheumatoid arthritis agrees well with 2010 ACR/EULAR criteria (Saraux A et al.…Abstract Number: 2605 • 2014 ACR/ARHP Annual Meeting
Profiling Ankylosing Spondylitis Patients Likely to Respond to NSAID Treatment
Background/Purpose Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease with unpredictable course of progression. Treatment of AS thus should be tailored according to disease…Abstract Number: 2584 • 2014 ACR/ARHP Annual Meeting
Smoking Is Not Associated with Response to TNF Blockers in Patients with Axial Spondyloarthritis
Background/Purpose Smoking has been reported as associated with increase disease activity, more functional impairment, poorer quality of life and more radiographic damages in patients (pts)…Abstract Number: 2583 • 2014 ACR/ARHP Annual Meeting
Unexpected High Prevalence of Cardiac Disease in Patients with Ankylosing Spondylitis
Background/Purpose Ankylosing spondylitis (AS) is associated with an increased cardiovascular (CV) risk that is caused by accelerated atherosclerosis as well as specific cardiac manifestations: valvular…